While you enjoy your restful sleep, the OXY-TREAT Dark Spots night cream works tirelessly at reducing your pigment spots. It lightens your skin during the night, combats uneven skin tone, and has a rich, thick texture which nourishes your complexion. Active ingredients with a high oxygen content as well as transdermal molecules reduce the visibility of hyperpigmentation and generally unify your skin tone.

Characteristics:

• expertly combats uneven skin tone while you sleep
• lightens and unifies skin during the night, reduces dark spots
• nourishes, has exceptional regenerative effects thanks to active oxygen
• protects from free radicals and oxidative stress
• with a rich and thick texture

Results of testing:
30 subjects participated in an effectivity study for the OXY-TREAT Dark Spots line (210 test subjects altogether), they used the cream for 30 days.

• 87% of the 30 subjects agreed the cream had a lightening effect
• 87% confirmed it reduces the visibility of dark spots
• 90% said it evens out skin tone
• 90% agreed they were happy with the results and would recommend the cream

Ingredients:

• kojic acid ‒ lightens spots
• sodium ascorbyl phosphate ‒ has lightening and antioxidative effects, protects skin from oxidative stress caused by free radicals
• glycyrrhetinic acid ‒ promotes skin lightening by diffusing melanin accumulated in the skin and accelerating the renewal of skin layers
• Labo patent CH 697 547 (extract from Dunaliella salina algae, vitamin F, zinc gluconate, niacinamide) ‒ enhances the ability of the Japanese pagoda tree extract to reduce the visibility of spots

How to apply:
Apply the OXY-TREAT Dark Spots night cream for hyperpigmentation to your face 1× a day, specifically every night. The cream can be used on its own, during the 2-week intense treatment, or in the subsequent weeks.

Notino tip:
For maximum effect, we recommend pairing this product with the OXY-TREAT Dark Spots intense treatment against hyperpigmentation. It also works really well with the OXY-TREAT Dark Spots day cream.